Norris Perne & French’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,220
Closed -$264K 148
2024
Q3
$264K Buy
2,220
+646
+41% +$86.2K 0.02% 125
2024
Q2
$225K Hold
1,574
0.02% 131
2024
Q1
$202K Buy
+1,574
New +$187K 0.01% 143
2021
Q3
Sell
-26,790
Closed -$1.12M 145
2021
Q2
$1.12M Sell
26,790
-750
-3% -$29.1K 0.1% 76
2021
Q1
$928K Sell
27,540
-7,218
-21% -$257K 0.09% 72
2020
Q4
$1.21M Buy
34,758
+790
+2% +$27.3K 0.11% 74
2020
Q3
$1.18M Hold
33,968
0.13% 73
2020
Q2
$1.11M Hold
33,968
0.14% 64
2020
Q1
$1.02M Hold
33,968
0.15% 63
2019
Q4
$983K Sell
33,968
-15,000
-31% -$415K 0.12% 69
2019
Q3
$1.27M Hold
48,968
0.16% 70
2019
Q2
$1.25M Hold
48,968
0.16% 68
2019
Q1
$1.28M Sell
48,968
-4,150
-8% -$102K 0.17% 67
2018
Q4
$1.22M Sell
53,118
-592
-1% -$13.2K 0.19% 66
2018
Q3
$1.27M Hold
53,710
0.17% 71
2018
Q2
$1.24M Sell
53,710
-13,380
-20% -$318K 0.18% 70
2018
Q1
$1.65M Hold
67,090
0.24% 70
2017
Q4
$1.8M Sell
67,090
-4,000
-6% -$102K 0.26% 69
2017
Q3
$1.71M Hold
71,090
0.27% 75
2017
Q2
$1.52M Hold
71,090
0.26% 76
2017
Q1
$1.22M Hold
71,090
0.23% 79
2016
Q4
$1.27M Hold
71,090
0.25% 76
2016
Q3
$1.48M Sell
71,090
-78,004
-52% -$1.93M 0.31% 71
2016
Q2
$4.01M Sell
149,094
-6,712
-4% -$184K 0.86% 44
2016
Q1
$4.22M Sell
155,806
-2,080
-1% -$55.7K 0.87% 39
2015
Q4
$4.58M Sell
157,886
-9,286
-6% -$257K 0.96% 38
2015
Q3
$4.53M Sell
167,172
-16,550
-9% -$469K 1.08% 32
2015
Q2
$5.03M Sell
183,722
-4,570
-2% -$128K 0.96% 41
2015
Q1
$5.03M Buy
188,292
+1,720
+0.9% +$39.6K 0.93% 40
2014
Q4
$3.95M Buy
186,572
+5,180
+3% +$116K 0.72% 48
2014
Q3
$4.32M Sell
181,392
-1,150
-0.6% -$26.5K 0.84% 43
2014
Q2
$4.22M Sell
182,542
-758
-0.4% -$16.7K 0.79% 45
2014
Q1
$4.18M Buy
183,300
+33,050
+22% +$704K 0.82% 43
2013
Q4
$2.78M Buy
150,250
+650
+0.4% +$11.3K 0.52% 55
2013
Q3
$2.53M Buy
149,600
+8,500
+6% +$143K 0.52% 57
2013
Q2
$2.19M Buy
+141,100
New +$2.35M 0.47% 60

Other funds holding NVO